ETON
Eton Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$41.07-2.95%
Price as of Jul 20, 2026
ETON profitability
Eton Pharmaceuticals, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 54.8%
- EBITDA margin
- 6.3%
- EBIT margin
- 2.3%
- Net margin
- -1.7%
- Free cash flow margin
- 17.8%
Returns
- Return on equity
- -4.8%
- Return on assets
- -1.5%
- Return on invested capital
- 4.8%
- Asset turnover
- 0.92x
Cash efficiency
- Cash from operations
- $15.8M
- Cash per share
- $0.72
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.